Skip to main content
TipRanks
Go Ultimate75% OFF

Neurocrine (1NBIX) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

1NBIX Analyst Ratings

Strong Buy
20Ratings
17Buy3Hold0Sell
Based on 20 analysts giving stock ratings to Neurocrine in the past 3 months

1NBIX Stock 12 Month Forecast

€186.46▲(25.23% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Neurocrine in the last 3 months. The average price target is EUR 186.46 with a high forecast of EUR 228.69 and a low forecast of EUR 135.59. The average price target represents a 25.23% change from the last price of EUR 148.90.
Highest Price Target€228.69Average Price Target€186.46Lowest Price Target€135.59

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IT:1NBIX
Price TargetArticle
Morgan Stanley€167.23→€172.65hold15.95%UpsideReiterated11/13/26
Wells Fargo€180.79buy21.41%UpsideAssigned11/03/26
Piper Sandler€189.83→€194.34buy30.52%UpsideReiterated11/03/26
Canaccord Genuity€189.83→€198.86buy33.56%UpsideReiterated11/03/26
Wedbush€168.13buy12.92%UpsideReiterated11/03/26
Oppenheimer€207.90buy39.63%UpsideReiterated11/03/26
Deutsche Bank €149.15→€158.19hold6.24%UpsideReiterated11/03/26
Bank of America Securities―buy―Reiterated11/03/26
Guggenheim€187.11→€202.48buy35.98%UpsideReiterated11/03/26
Bernstein€197.06buy32.34%UpsideReiterated11/03/26
TD Cowen€198.86buy33.56%UpsideReiterated11/03/26
J.P. Morgan―buy―Reiterated11/02/26
Cantor Fitzgerald€194.34buy30.52%UpsideReiterated11/02/26
RBC Capital€169.03→€171.75buy15.34%UpsideReiterated11/02/26
BMO Capital€135.59hold-8.94%DownsideReiterated11/02/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
SLDBSolid Biosciences
RDNTRadnet
PTGXProtagonist Therapeutics
HROWHarrow Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Neurocrine

3 Months
Jay Olson
Jay OlsonOppenheimer
Success Rate18/27 ratings generated profit
67%
Average Return
+3.33%

Copying Jay Olson's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.33% per trade.

1 Year
Tazeen Ahmad
Tazeen AhmadBank of America Securities
Success Rate16/19 ratings generated profit
84%
Average Return
+12.88%

Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +12.88% per trade.

2 Years
Tazeen Ahmad
Tazeen AhmadBank of America Securities
Success Rate18/19 ratings generated profit
95%
Average Return
+23.77%

Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 94.74% of your transactions generating a profit, with an average return of +23.77% per trade.

1NBIX Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 1NBIX
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy41466
Buy4436351722
Hold891076
Sell00000
Strong Sell00000
total5646493034

In the current month, 1NBIX has received 28 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. 1NBIX average Analyst price target in the past 3 months is 186.46.

1NBIX Financial Forecast

€0€0.75€1.5€2.25€3Q1 2026Q3 2026Q4 2026
High€2.88
Consensus€1.88
Low€1.24

1NBIX Earnings Forecast

Next quarter’s earnings estimate for 1NBIX is EUR 1.88 with a range of EUR 1.24 to EUR 2.88. The previous quarter’s EPS was EUR 1.78. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€730.8M€838.4M€946M€1.1B€1.2BQ1 2026Q3 2026Q4 2026
High€1.16B
Consensus€991M
Low€957M

1NBIX Sales Forecast

Next quarter’s sales forecast for 1NBIX is EUR 991.17M with a range of EUR 957.15M to EUR 1.16B. The previous quarter’s sales results were EUR 1.02B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

1NBIX Stock Forecast FAQ

What is IT:1NBIX’s average 12-month price target, according to analysts?
Based on analyst ratings, Neurocrine’s 12-month average price target is €186.46.
What is IT:1NBIX’s upside potential, based on the analysts’ average price target?
Neurocrine has 25.23% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Neurocrine a Buy, Sell or Hold?
Neurocrine has a consensus rating of Strong Buy, which is based on 17 buy ratings, 3 hold ratings and 0 sell ratings.
What is Neurocrine’s share price target?
The average share price target for Neurocrine is €186.46. This is based on 20 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €228.69, and the lowest forecast is €135.59. The average share price target represents a 25.23% increase from the current price of €148.9.
What do analysts say about Neurocrine?
Neurocrine’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Street analysts.
How can I buy shares of Neurocrine?
To buy shares of IT:1NBIX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.